This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
4
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- HC Wainwright & Co. analyst Edward White downgraded the rating for Adicet Bio, Inc. (NASDAQ:ACET) from Buy to Neutral. Adicet Bio shares fell 3.4% to close at $1.43 on Tuesday. See how other analysts view this stock.
- B of A Securities analyst Graham Perry downgraded Novartis AG (NYSE:NVS) from Buy to Neutral and lowered the price target from $135 to $130. …
Full story available on Benzinga.com
Visited 4 times, 1 visit(s) today